Prescription Drug Pricing
Podcasts
On the Mic with David Axelrod
The Council's Joel Wood follows up with political analyst David Axelrod for an e...
December 14, 2020
Health+Benefits
Runaway Freight Train
Transparency alone isn’t enough to lower drug costs, but it’s a critical ste...
November 13, 2020
Health+Benefits
COVID-19 Solutions Fast-Tracked
Gilead relinquished its orphan drug status for remdesivir shortly after receivin...
May 31, 2020
Health+Benefits
Out of Reach?
New models for financing and providing rare disease treatment could make for a s...
May 31, 2020
Health+Benefits
Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
April 27, 2020
Health+Benefits
PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on...
March 1, 2020
Health+Benefits
Hospitals and Insurers Team Up to Manufacture Generic Drugs
Unlikely advocates support lowering prescription drug costs
February 19, 2020
Health+Benefits
What Prescription Drug Importation Could Mean for Brokers
Q&A with David Shore, SVP, Enterprise Strategy & Risk Management at Borislow Ins...
August 14, 2019
Health+Benefits
It’s Personal
Can insurers and PBMs harness their combined data to truly know the patient bett...
May 24, 2019
Health+Benefits
Prescription Back-Door Discounts
Q&A with Steve Wojcik, VP, National Business Group on Health; Caleb Alexander, c...
April 19, 2019